Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
4.81M
-
Shares change
-
+366K
-
Total reported value, excl. options
-
$7.9M
-
Value change
-
+$542K
-
Put/Call ratio
-
0.47
-
Number of buys
-
10
-
Number of sells
-
-11
-
Price
-
$1.64
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2021
39 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q2 2021.
IGC Pharma, Inc. - COM NEW (IGC) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.81M shares
.
Largest 10 shareholders include Davy Global Fund Management Ltd (1.11M shares), BlackRock Inc. (843K shares), VANGUARD GROUP INC (654K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (414K shares), RENAISSANCE TECHNOLOGIES LLC (298K shares), GEODE CAPITAL MANAGEMENT, LLC (272K shares), STATE STREET CORP (217K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (209K shares), Virtu Financial LLC (190K shares), and DEARBORN PARTNERS LLC (96.9K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.